NEW YORK CITY, NY / ACCESS Newswire / October 19, 2025 / NEW YORK, NY / ACCESS Newswire / October 19, 2025 / If you suffered a loss on your RCI Hospitality Holdings, Inc. (NASDAQ:RICK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more […]
NEW YORK CITY, NY / ACCESS Newswire / October 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Dow Inc. ("Dow" or the "Company") (NYSE:DOW) and certain officers.�� The class action, filed in the United States District Court for the Eastern District of Michigan, Northern Division, and docketed under
NEW YORK CITY, NY / ACCESS Newswire / October 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Fluor Corporation ("Fluor" or the "Company") (NYSE:FLR) and certain officers.�� The class action, filed in the United States District Court for the Northern District of Texas, Dallas Division, and docketed under
NEW YORK CITY, NY / ACCESS Newswire / October 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Tronox Holdings Plc ("Tronox" or the "Company") (NYSE:TROX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / October 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE:MOH).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / October 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cepton, Inc. ("Cepton" or the "Company") (NASDAQ:CPTN) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08571, is
(NASDAQ:TLX), NEW YORK, Oct. 19, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting from allegations that Telix may have issued materially misleading business information to the investing public. SO WHAT: If you
TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NASDAQ: TLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire October 19, 2025 NEW YORK, Oct. 19, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on
NEW YORK CITY, NY / ACCESS Newswire / October 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against C3.ai, Inc. ("C3" or the "Company") (NYSE:AI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / October 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate ("Cytokinetics" or the "Company") (NASDAQ:CYTK).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged